Evidence map›Paper›PMID 37190159›Full record

ArticleCancers2023

Perinucleolar Compartment (PNC) Prevalence as an Independent Prognostic Factor in Pediatric Ewing Sarcoma: A Multi-Institutional Study.

Elizabeth Gonzalez, Atif A Ahmed, Laura McCarthy, Katherine Chastain, Sahibu Habeebu, Marta Zapata-Tarres, Rocio Cardenas-Cardos, Liliana Velasco-Hidalgo, Celso Corcuera-Delgado, Rodolfo Rodriguez-Jurado and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Elizabeth GonzalezDepartment of Pediatrics, Division of Hematology & Oncology, Children's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA.
Atif A AhmedDepartment of Pathology, Seattle Children's Hospital, Seattle, WA 98105, USA.ORCID 0000-0002-8791-5785
Laura McCarthyDepartment of Pediatrics, Division of Hematology & Oncology, Children's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA.
Katherine ChastainDepartment of Pediatrics, Division of Hematology & Oncology, Children's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA.
Sahibu HabeebuDepartment of Pathology & Laboratory Medicine, Children's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA.
Marta Zapata-TarresResearch Coordination Mexican Institute of Social Security Foundation, Mexico City 06600, Mexico.ORCID 0000-0002-0737-924X
Rocio Cardenas-CardosDepartamento de Oncología Pediátrica, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
Liliana Velasco-HidalgoDepartamento de Oncología Pediátrica, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
Celso Corcuera-DelgadoDepartamento de Patología Pediátrica, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
Rodolfo Rodriguez-JuradoDepartamento de Patología Pediátrica, Instituto Nacional de Pediatría, Mexico City 04530, Mexico.
Lilia García-RodríguezFacultad de Medicina, Universidad de Monterrey, San Pedro Garza García 66238, Mexico.
Alejandro ParralesDepartment of Pediatrics, Division of Hematology & Oncology, Children's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA.
Tomoo IwakumaDepartment of Pediatrics, Division of Hematology & Oncology, Children's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA.
Midhat S FarooqiDepartment of Pathology & Laboratory Medicine, Children's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA.ORCID 0000-0002-5238-1349
Brian LeeDepartment of Health Services and Outcomes Research, Children's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA.
Scott J WeirDepartment of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66103, USA.ORCID 0000-0002-8020-434X
Terrie G FlattDepartment of Pediatrics, Division of Hematology & Oncology, Children's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA.
Children's Mercy Hospital · USInstituto Nacional de Pediatria · MXMexican Social Security Institute · MXSeattle Children's Hospital · USThe University of Kansas Cancer Center · USUniversity of Monterrey · MX

Funding

Masonic Cancer Alliance N/A
6 · The paper itself

Abstract

The perinucleolar compartment (PNC) is a small nuclear body that plays important role in tumorigenesis. PNC prevalence correlates with poor prognosis and cancer metastasis. Its expression in pediatric Ewing sarcoma (EWS) has not previously been documented. In this study, we analyzed 40 EWS tumor cases from Caucasian and Hispanic patients for PNC prevalence by immunohistochemical detection of polypyrimidine tract binding protein and correlated the prevalence with dysregulated microRNA profiles. EWS cases showed staining ranging from 0 to 100%, which were categorized as diffuse (≥77%, n = 9, high PNC) or not diffuse (<77%, n = 31) for low PNC. High PNC prevalence was significantly higher in Hispanic patients from the US (n = 6,

Indexed as

biomarkerEwing sarcomametastasismicroRNAperinucleolar compartment

Identifiers

PMID37190159
PMCPMC10136508
OpenAlexW4362733692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.